Milk fat globule membrane supplementation modulates the gut microbiota and attenuates metabolic endotoxemia in high-fat diet-fed mice

Journal of Functional Foods

Volumn 47, Issue , 2018, Pages 56-65

  Li, Tiange ^a   Gao, Jing ^a   Du, Min ^b   Mao, Xueying ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Gut microbiota; Inflammation; Metabolic endotoxemia; Milk fat globule membrane

Indexed keywords

EID: 85047602596     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2018.05.038     Document Type: Article

References (52)

1. Aziz, M.M., Ishihara, S., Mishima, Y., Oshima, N., Moriyama, I., Yuki, T., Kinoshita, Y., MFG-E8 attenuates intestinal inflammation in murine experimental colitis by modulating osteopontin-dependent alpha(v)beta(3) integrin signaling. Journal of Immunology 182:11 (2009), 7222–7232.
2. Baars, A., Oosting, A., Engels, E., Kegler, D., Kodde, A., Schipper, L., van der Beek, E.M., Milk fat globule membrane coating of large lipid droplets in the diet of young mice prevents body fat accumulation in adulthood. British Journal of Nutrition 115:11 (2016), 1930–1937.
3. Bhinder, G., Allaire, J.M., Garcia, C., Lau, J.T., Chan, J.M., Ryz, N.R., Vallance, B.A., Milk fat globule membrane supplementation in formula modulates the neonatal gut microbiome and normalizes intestinal development. Scientific Reports, 7, 2017, 45274.
4. Biddle, A., Stewart, L., Blanchard, J., Leschine, S., Untangling the genetic basis of fibrolytic specialization by Lachnospiraceae and Ruminococcaceae in diverse gut communities. Diversity 5:3 (2013), 627–640.
5. Bu, H., Zuo, X., Wang, X., Ensslin, M.A., Koti, V., Hsueh, W., Tan, X., Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. Journal of Clinical Investigation 117:12 (2007), 3673–3683.
6. Byrne, C.S., Chambers, E.S., Morrison, D.J., Frost, G., The role of short chain fatty acids in appetite regulation and energy homeostasis. International Journal of Obesity 39:9 (2015), 1331–1338.
7. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Burcelin, R., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:7 (2007), 1761–1772.
8. Cani, P.D., Bibiloni, R., Knauf, C., Neyrinck, A.M., Neyrinck, A.M., Delzenne, N.M., Burcelin, R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:6 (2008), 1470–1481.
9. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Delzenne, N.M., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:8 (2009), 1091–1103.
10. de La Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C., Raybould, H.E., Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. AJP: Gastrointestinal and Liver. Physiology 299:2 (2010), G440–G448.
11. Demmer, E., Van Loan, M.D., Rivera, N., Rogers, T.S., Gertz, E.R., German, J.B., Zivkovic, A.M., Addition of a dairy fraction rich in milk fat globule membrane to a high-saturated fat meal reduces the postprandial insulinaemic and inflammatory response in overweight and obese adults. Journal of Nutritional Science, 5, 2016.
12. Ding, S., Lund, P.K., Role of intestinal inflammation as an early event in obesity and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care 14:4 (2011), 328–333.
13. Dong, J.L., Zhu, Y.Y., Ma, Y.L., Xiang, Q.S., Shen, R.L., Liu, Y.Q., Oat products modulate the gut microbiota and produce anti-obesity effects in obese rats. Journal of Functional Foods 25 (2016), 408–420.
14. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J., Paquot, N., Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice 105:2 (2014), 141–150.
15. Evans, C.C., LePard, K.J., Kwak, J.W., Stancukas, M.C., Laskowski, S., Dougherty, J., Leone, V., Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity. PLoS One, 3(9), 2014, e92193.
16. Geurts, L., Neyrinck, A.M., Delzenne, N.M., Knauf, C., Cani, P.D., Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics. Beneficial Microbes 5:1 (2014), 3–17.
17. Gil-Cardoso, K., Ginés, I., Pinent, M., Ardévol, A., Blay, M., Terra, X., Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity. Nutrition Research Reviews 29:2 (2016), 234–248.
18. Groschwitz, K.R., Hogan, S.P., Intestinal barrier function: Molecular regulation and disease pathogenesis. Journal of Allergy and Clinical Immunology 124:1 (2009), 3–20.
19. Guo, S., Nighot, M., Al-Sadi, R., Alhmoud, T., Nighot, P., Ma, T.Y., Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. Journal of Immunology 195:10 (2015), 4999–5010.
20. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.J., Review article: The role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics 27:2 (2008), 104–119.
21. Hong, J., Jia, Y.M., Pan, S., Jia, L.F., Li, H.F., Han, Z.Q., Zhao, R.Q., Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice. Oncotarget 7:35 (2016), 56071–56082.
22. Huang, Y.P., Gao, S.X., Chen, J.L., Albrecht, E., Zhao, R.Q., Yang, X.J., Maternal butyrate supplementation induces insulin resistance associated with enhanced intramuscular fat deposition in the offspring. Oncotarget 8:8 (2016), 13073–13084.
23. Jiang, T., Gao, X., Wu, C., Tian, F., Lei, Q., Bi, J., Wang, X., Apple-derived pectin modulates gut microbiota, improves gut barrier function, and attenuates metabolic endotoxemia in rats with diet-induced obesity. Nutrients, 8(3), 2016, 126.
24. Kameyama, K., Itoh, K., Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes and Environments 29:4 (2014), 427–430.
25. Kim, K., Gu, W., Lee, I., Joh, E., Kim, D., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One, 7(10), 2012, e47713.
26. Kim, K., Lee, I., Gu, W., Hyam, S.R., Kim, D., β-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB pathway. Molecular Nutrition & Food Research 58:5 (2014), 963–972.
27. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 102:31 (2005), 11070–11075.
28. Li, X., Guo, J., Ji, K., Zhang, P., Bamboo shoot fiber prevents obesity in mice by modulating the gut microbiota. Scientific Reports, 6, 2016, 32953.
29. LMitchell, A. J., Dinudom, A., Oscarsson, J., Cook, D. I., Hunt, N. H., Caterson, I. D., & Holmes, A. J. (2012). Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One, 7(3), e34233.
30. Luo, H., Guo, P., Zhou, Q., Role of TLR4/NF-kappa B in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia. PLoS One, 7(10), 2012, e46291.
31. Moreira, A. P. B., Texeira, T. F. S., Ferreira, A. B., Do Carmo Gouveia Peluzio, M., & de Cássia Gonçalves Alfenas, R. (2012). Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. British Journal of Nutrition, 108(5), 801–809.
32. Moschen, A.R., Wieser, V., Tilg, H., Dietary factors: Major regulators of the gut's microbiota. Gut and Liver 6:4 (2012), 411–416.
33. Nadal, I., Santacruz, A., Marcos, A., Warnberg, J., Garagorri, J.M., Garagorri, M., Sanz, Y., Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. International Journal of Obesity 33:7 (2009), 758–767.
34. Norris, G.H., Blesso, C.N., Dietary and endogenous sphingolipid metabolism in chronic inflammation. Nutrients, 9(11), 2017, 1180.
35. Norris, G.H., Jiang, C., Ryan, J., Porter, C.M., Blesso, C.N., Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice. Journal of Nutritional Biochemistry 30:38 (2016), 93–101.
36. Park, S.K., Kim, M.S., Bae, J.W., Blautia faecis sp. nov., isolated from human faeces. International Journal of Systematic and Evolutionary Microbiology 63:Pt 2 (2013), 599–603.
37. Qiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., Le, G., Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food & Function 5:6 (2014), 1241–1249.
38. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Wang, J., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:7418 (2012), 55–60.
39. Rahat-Rozenbloom, S., Fernandes, J., Gloor, G.B., Wolever, T.M.S., Evidence for greater production of colonic short chain fatty acids in overweight than lean humans. International Journal of Obesity 38:12 (2014), 1525–1531.
40. Rooks, M.G., Veiga, P., Wardwell-Scott, L.H., Tickle, T., Segata, N., Michaud, M., Garrett, W.S., Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME Journal 8:7 (2014), 1403–1417.
41. Sánchez-Juanes, F., Alonso, J.M., Zancada, L., Hueso, P., Glycosphingolipids from bovine milk and milk fat globule membranes: A comparative study. Adhesion to enterotoxigenic Escherichia coli strains. Biological Chemistry 390:1 (2009), 31–40.
42. Schloss, P.D., Gevers, D., Westcott, S.L., Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One, 6(12), 2011, e27310.
43. Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C., Hardt, P.D., Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18:1 (2010), 190–195.
44. Serino, M., Luche, E., Gres, S., Baylac, A., Berge, M., Cenac, C., Klopp, C., Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61:4 (2012), 543–553.
45. Snow, D.R., Ward, R.E., Olsen, A., Jimenez-Flores, R., Hintze, K.J., Membrane-rich milk fat diet provides protection against gastrointestinal leakiness in mice treated with lipopolysaccharide. Journal of Dairy Science 94:5 (2011), 2201–2212.
46. Sprong, R.C., Hulstein, M.F.E., Lambers, T.T., van der Meer, R., Sweet buttermilk intake reduces colonisation and translocation of Listeria monocytogenes in rats by inhibiting mucosal pathogen adherence. British Journal of Nutrition 108:11 (2012), 2026–2033.
47. Suzuki, T., Regulation of intestinal epithelial permeability by tight junctions. Cellular and Molecular Life Sciences 70:4 (2013), 631–659.
48. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1131.
49. Turner, J.R., Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology 9:11 (2009), 799–809.
50. Ulevitch, R.J., Aderem, A., Toll-like receptors in the induction of the innate immune response. Nature 406:6797 (2000), 782–787.
51. Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., Shen, J., Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME Journal 9:1 (2015), 1–15.
52. Zhou, X., Han, D., Xu, R., Li, S., Wu, H., Qu, C., Zhao, Y., A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. PLoS One, 9(12), 2014, e115148.